Summit X LLC purchased a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 2,306 shares of the exchange traded fund’s stock, valued at approximately $208,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Kohmann Bosshard Financial Services LLC acquired a new stake in SPDR S&P Biotech ETF during the fourth quarter worth approximately $29,000. Golden State Wealth Management LLC acquired a new stake in SPDR S&P Biotech ETF during the fourth quarter worth approximately $29,000. Avior Wealth Management LLC grew its stake in SPDR S&P Biotech ETF by 393.6% during the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after purchasing an additional 307 shares during the period. Tidemark LLC grew its stake in SPDR S&P Biotech ETF by 101.5% during the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after purchasing an additional 199 shares during the period. Finally, Bank of Jackson Hole Trust acquired a new stake in SPDR S&P Biotech ETF during the fourth quarter worth approximately $43,000.
SPDR S&P Biotech ETF Price Performance
NYSEARCA XBI opened at $87.15 on Thursday. The business has a 50 day simple moving average of $90.28 and a 200 day simple moving average of $95.02. The stock has a market capitalization of $5.75 billion, a P/E ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Read More
- Five stocks we like better than SPDR S&P Biotech ETF
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- Profitably Trade Stocks at 52-Week Highs
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Why Energy Transfer Belongs on Your Watchlist
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.